{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:02:17Z","timestamp":1771650137382,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vascn.2025.108393","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T06:11:32Z","timestamp":1756707092000},"page":"108393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PolyCheck: A hybrid model for predicting polypharmacy-induced adverse drug reactions in tuberculosis treatment using heterogenous drug-target-ADR networks"],"prefix":"10.1016","volume":"136","author":[{"given":"Ahmad Tamim","family":"Ghafari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuslina","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizaton Hazizul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu Bakar Abdul","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qand Agha","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vascn.2025.108393_bb0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5455\/njppp.2015.5.2005201557","article-title":"Drug interaction and its implication in clinical practice and personalized medicine","volume":"5","author":"Abubakar","year":"2015","journal-title":"National Journal of Physiology, Pharmacy and Pharmacology"},{"issue":"11","key":"10.1016\/j.vascn.2025.108393_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112133","article-title":"Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: A prospective cohort study","volume":"9","author":"Ahmed","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2025.108393_bb0015","first-page":"197","article-title":"Factors associated with tuberculosis treatment outcomes among tuberculosis patients attending tuberculosis treatment centres in 2016\u20132017 in Mogadishu, Somalia","volume":"28","author":"Ali","year":"2017","journal-title":"Pan African Medical Journal"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-19999-4","article-title":"Prediction of drug-drug interaction events using graph neural networks based feature extraction","volume":"12","author":"Al-Rabeah","year":"2022","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.vascn.2025.108393_bb0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/ijms20020386","article-title":"Network-based assessment of adverse drug reaction risk in polypharmacy using high-throughput screening data","volume":"20","author":"de Anda-J\u00e1uregui","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"18","key":"10.1016\/j.vascn.2025.108393_bb0030","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/bioinformatics\/btab174","article-title":"Polypharmacy side-effect prediction with enhanced interpretability based on graph feature attention network","volume":"37","author":"Bang","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vascn.2025.108393_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.mpaic.2017.04.006","article-title":"Mechanisms of drug interactions: Pharmacodynamics and pharmacokinetics","author":"Corrie","year":"2017","journal-title":"Anaesthesia & Intensive Care Medicine."},{"issue":"12","key":"10.1016\/j.vascn.2025.108393_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000116","article-title":"Drug-target-ADR network and possible implications of structural variants in adverse events","volume":"39","author":"Dafniet","year":"2020","journal-title":"Molecular Informatics"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12880-024-01349-7","article-title":"Advancing medical imaging: Detecting polypharmacy and adverse drug effects with graph convolutional networks (GCN)","volume":"24","author":"Dara","year":"2024","journal-title":"BMC Medical Imaging"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12875-023-02070-0","article-title":"The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: A retrospective cohort study","volume":"24","author":"Doumat","year":"2023","journal-title":"BMC Primary Care"},{"issue":"5","key":"10.1016\/j.vascn.2025.108393_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21315\/mjms2018.25.5.10","article-title":"Evaluation of adverse reactions induced by anti-tuberculosis drugs in hospital Pulau Pinang","volume":"25","author":"Fei","year":"2018","journal-title":"Malaysian Journal of Medical Sciences"},{"key":"10.1016\/j.vascn.2025.108393_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114631","article-title":"deepMDDI: A deep graph convolutional network framework for multi-label prediction of drug-drug interactions","volume":"646","author":"Feng","year":"2022","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.vascn.2025.108393_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jbi.2017.04.021","article-title":"Computational prediction of drug-drug interactions based on drugs functional similarities","volume":"70","author":"Ferdousi","year":"2017","journal-title":"Journal of Biomedical Informatics"},{"key":"10.1016\/j.vascn.2025.108393_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baab068","article-title":"Mining drug-target and drug-adverse drug reaction databases to identify target\u2013adverse drug reaction relationships","volume":"2021","author":"Galletti","year":"2021","journal-title":"Database"},{"key":"10.1016\/j.vascn.2025.108393_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1617142","article-title":"PolyLLM: Polypharmacy side effect prediction via LLM-based SMILES encodings","volume":"16","author":"Hakim","year":"2025","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.vascn.2025.108393_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.814858","article-title":"A review of approaches for predicting drug\u2013drug interactions based on machine learning","volume":"12","author":"Han","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.vascn.2025.108393_bb0085","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1038\/s41598-022-09954-8","article-title":"On evaluation metrics for medical applications of artificial intelligence","volume":"12","author":"Hicks","year":"2022","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.vascn.2025.108393_bb0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s40484-016-0081-2","article-title":"Performance measures in evaluating machine learning-based bioinformatics predictors for classifications","volume":"4","author":"Jiao","year":"2016","journal-title":"Quantitative Biology"},{"key":"10.1016\/j.vascn.2025.108393_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jclinepi.2018.10.014","article-title":"Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: Proposal for standard definitions beyond the term polypharmacy","volume":"106","author":"Kadam","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.vascn.2025.108393_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4749668","article-title":"PU-GNN: A positive-unlabeled learning method for polypharmacy side-effects detection based on graph neural networks","volume":"2024","author":"Keshavarz","year":"2024","journal-title":"International Journal of Intelligent Systems"},{"issue":"D1","key":"10.1016\/j.vascn.2025.108393_bb0105","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2016","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.vascn.2025.108393_bb0110","first-page":"648","article-title":"PM-TOM: A method for finding personalized polypharmacy therapies with minimal adverse drug-drug, drug-gene and drug-condition interactions","volume":"270","author":"Kulenovic","year":"2020","journal-title":"Studies in Health Technology and Informatics"},{"key":"10.1016\/j.vascn.2025.108393_bb0115","unstructured":"Kumar, A. S., & Rekha, D. R. (2021). A critical review on predicting drug-drug reactions using machine learning techniques. International Journal of Computer and Neural Engineering, 7(1). Retrieved from https:\/\/scidoc.org\/IJCNE.php."},{"issue":"4","key":"10.1016\/j.vascn.2025.108393_bb0120","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/e25040676","article-title":"Ranking plant network nodes based on their centrality measures","volume":"25","author":"Kumar","year":"2023","journal-title":"Entropy"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0125","first-page":"1331","article-title":"Adverse drug reactions of primary anti-tuberculosis drugs among tuberculosis patients treated in chest clinic","volume":"3","author":"Kurniawati","year":"2012","journal-title":"International Journal of Pharma and Life Sciences"},{"issue":"7","key":"10.1016\/j.vascn.2025.108393_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236109","article-title":"The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis","volume":"15","author":"Kwon","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2025.108393_bb0135","series-title":"2017 4th NAFOSTED conference on information and computer science","first-page":"242","article-title":"Random walk with restart: A powerful network propagation algorithm in bioinformatics field","author":"Le","year":"2017"},{"key":"10.1016\/j.vascn.2025.108393_bb0140","first-page":"142","article-title":"Pharmacogenomic approaches for automated medication risk assessment in people with polypharmacy","volume":"2017","author":"Liu","year":"2018","journal-title":"AMIA Joint Summits on Translational Science Proceedings"},{"issue":"12","key":"10.1016\/j.vascn.2025.108393_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae706","article-title":"Fast polypharmacy side effect prediction using tensor factorization","volume":"40","author":"Lloyd","year":"2024","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12859-021-04298-y","article-title":"A neural network-based method for polypharmacy side effects prediction","volume":"22","author":"Masumshah","year":"2021","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12879-019-3919-1","article-title":"Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals, Ethiopia: A retrospective cohort study","volume":"19","author":"Merid","year":"2019","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.vascn.2025.108393_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.651720","article-title":"Role of pharmacogenetics in adverse drug reactions: An update towards personalized medicine","volume":"12","author":"Micaglio","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"10.1016\/j.vascn.2025.108393_bb0165","first-page":"514","article-title":"Inappropriate polypharmacy: Reducing the burden of multiple medication","volume":"7","author":"Milton","year":"2009","journal-title":"CME Geriatric Medicine"},{"issue":"12","key":"10.1016\/j.vascn.2025.108393_bb0170","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1345\/aph.1M354","article-title":"Factors associated with multiple medication use in different age groups","volume":"43","author":"Moen","year":"2009","journal-title":"Annals of Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13104-022-06096-y","article-title":"Towards a guideline for evaluation metrics in medical image segmentation","volume":"15","author":"M\u00fcller","year":"2022","journal-title":"BMC Research Notes"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2251-6581-11-28","article-title":"Diabetes and tuberculosis: A review of the role of optimal glycemic control","volume":"11","author":"Niazi","year":"2012","journal-title":"Journal of Diabetes & Metabolic Disorders"},{"issue":"4","key":"10.1016\/j.vascn.2025.108393_bb0190","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1016\/S2666-7568(24)00007-2","article-title":"Prevalence of multimorbidity and polypharmacy among adults and older adults: A systematic review","volume":"5","author":"Nicholson","year":"2024","journal-title":"The Lancet Healthy Longevity"},{"issue":"6","key":"10.1016\/j.vascn.2025.108393_bb0195","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cpt.1434","article-title":"Pharmacodynamic drug\u2013drug interactions","volume":"105","author":"Niu","year":"2019","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2025.108393_bb0200","first-page":"449","article-title":"Predicting polypharmacy side-effects using knowledge graph Embeddings","volume":"2020","author":"Nov\u00e1\u010dek","year":"2020","journal-title":"AMIA Joint Summits on Translational Science proceedings AMIA Joint Summits on Translational Science"},{"issue":"7","key":"10.1016\/j.vascn.2025.108393_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055551","article-title":"Adverse drug reactions, multimorbidity and polypharmacy: A prospective analysis of 1 month of medical admissions","volume":"12","author":"Osanlou","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0210","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/phcfm.v10i1.1651","article-title":"Tuberculosis non-communicable disease comorbidity and multimorbidity in public primary care patients in South Africa","volume":"10","author":"Peltzer","year":"2018","journal-title":"African Journal of Primary Health Care & Family Medicine"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0215","first-page":"37","article-title":"Evaluation: From precision, recall and F-measure to ROC, informedness, markedness and correlation","volume":"2","author":"Powers","year":"2011","journal-title":"International Journal of Machine Learning Technologies"},{"issue":"4","key":"10.1016\/j.vascn.2025.108393_bb0220","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1109\/TCBB.2021.3081268","article-title":"A comprehensive review of computational methods for drug-drug interaction detection","volume":"19","author":"Qiu","year":"2022","journal-title":"IEEE\/ACM Transactions on Computational Biology and Bioinformatics"},{"key":"10.1016\/j.vascn.2025.108393_bb0225","doi-asserted-by":"crossref","first-page":"15724","DOI":"10.1038\/s41598-024-66611-y","article-title":"Author correction: Evaluation metrics and statistical tests for machine learning","volume":"14","author":"Rainio","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2025.108393_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2020.100007","article-title":"Tuberculosis and pharmacological interactions: A narrative review","volume":"2","author":"Riccardi","year":"2021","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"issue":"3","key":"10.1016\/j.vascn.2025.108393_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118432","article-title":"The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets","volume":"10","author":"Saito","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vascn.2025.108393_bb0245","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"International Journal of Medical Sciences"},{"issue":"4","key":"10.1016\/j.vascn.2025.108393_bb0250","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.18203\/2394-6040.ijcmph20171326","article-title":"A study on comorbidities and treatment outcome based on updated definitions among tuberculosis patients registered at a tuberculosis unit, Bangalore","volume":"4","author":"Shivalingaiah","year":"2017","journal-title":"International Journal of Community Medicine and Public Health"},{"key":"10.1016\/j.vascn.2025.108393_bb0255","author":"STRING"},{"issue":"D1","key":"10.1016\/j.vascn.2025.108393_bb0260","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"10.1016\/j.vascn.2025.108393_bb0265","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Research"},{"issue":"12","key":"10.1016\/j.vascn.2025.108393_bb0270","article-title":"Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis","volume":"14","author":"Torres","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2025.108393_bb0275","doi-asserted-by":"crossref","first-page":"e0207","DOI":"10.1590\/0037-8682-0207-2019","article-title":"Association of adverse drug reaction to anti-tuberculosis medication with quality of life in patients in a tertiary referral hospital","volume":"53","author":"Valadares","year":"2020","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"3","key":"10.1016\/j.vascn.2025.108393_bb0280","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/bioinformatics\/bty637","article-title":"Random walk with restart on multiplex and heterogeneous biological networks","volume":"35","author":"Valdeolivas","year":"2019","journal-title":"Bioinformatics"},{"issue":"Database issue","key":"10.1016\/j.vascn.2025.108393_bb0285","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: A comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.vascn.2025.108393_bb0290","series-title":"Framework for collaborative action on tuberculosis and comorbidities","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.vascn.2025.108393_bb0295","series-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/acs.chemrestox.9b00238","article-title":"Prediction of adverse drug reactions by combining biomedical tripartite network and graph representation model","volume":"33","author":"Xue","year":"2020","journal-title":"Chemical Research in Toxicology"},{"issue":"1","key":"10.1016\/j.vascn.2025.108393_bb0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12859-016-1415-9","article-title":"Predicting potential drug-drug interactions by integrating chemical, biological, phenotypic and network data","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Bioinformatics"},{"issue":"13","key":"10.1016\/j.vascn.2025.108393_bb0310","doi-asserted-by":"crossref","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","article-title":"Modeling polypharmacy side effects with graph convolutional networks","volume":"34","author":"Zitnik","year":"2018","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1016\/j.vascn.2025.108402","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000}},{"DOI":"10.1016\/j.vascn.2025.108402","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925008135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925008135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:05:29Z","timestamp":1771646729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871925008135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"alternative-id":["S1056871925008135"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2025.108393","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PolyCheck: A hybrid model for predicting polypharmacy-induced adverse drug reactions in tuberculosis treatment using heterogenous drug-target-ADR networks","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2025.108393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108393"}}